| View |
|
DRP-11661-01
|
Propofol
|
Profocent
|
10 mg / mL
|
Emulsion for Injection (I.V.)
|
General Anesthetic
|
Daewon Pharm Co., Ltd.
|
Korea
|
CLIDP Conversion
|
11 July 2022
|
07 April 2027
|
| View |
|
DRP-11700-01
|
Omeprazole (as sodium)
|
OROMEP
|
40 mg
|
Lyophilized Powder for Intravenous Injection/Infusion
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
11 July 2022
|
25 April 2027
|
| View |
|
BRP-103
|
EPOETIN ALFA (RECOMBINANT HUMAN ERYTHROPOIETIN)
|
EPOKINE
|
4,000 IU/ 0.4 mL
|
SOLUTION FOR INJECTION (IV/SC)
|
HEMATOPOIETIC GROWTH FACTOR
|
HK inno.N CORPORATION
|
KOREA
|
Renewal
|
08 July 2022
|
25 July 2027
|
| View |
|
BRP-104
|
EPOETIN ALFA (RECOMBINANT HUMAN ERYTHROPOIETIN)
|
EPOKINE
|
2,000 IU/ 0.5 mL
|
SOLUTION FOR INJECTION (IV/SC)
|
HEMATOPOIETIC GROWTH FACTOR
|
HK inno.N CORPORATION
|
KOREA
|
Renewal
|
08 July 2022
|
25 July 2027
|
| View |
|
DRP-1543-02
|
IRON (AS FERROUS SULFATE HEPTAHYDRATE)
|
TG HEALTHY KIDZ
|
44MG/5ML
|
SYRUP (EQUIVALENT TO 220MG FERROUS SULFATE HEPTAHYDRATE)
|
ANTIANEMIC (IRON PREPARATIONS)
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
Renewal
|
05 April 2023
|
13 March 2028
|
| View |
|
DRP-1573-02
|
IRON
|
TG Healthy Todz
|
25MG/ML
|
SYRUP (ORAL DROPS) (EQUIVALENT TO 125MG FERROUS SULFATE AS HEPTAHYDRATE PER ML)
|
ANTI-ANEMIC PREPARATIONS
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
09 January 2026
|
| View |
|
DRP-3555-08
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
TAZOGEN
|
4 g/500 mg
|
Powder for Injection (I.V.)
|
Antibacterial
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
02 July 2024
|
26 August 2029
|
| View |
|
DRP-4072-09
|
Cefixime (as trihydrate)
|
Fixsil-200
|
200 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
08 July 2022
|
24 October 2027
|
| View |
|
DRP-4207-07
|
Carbocisteine
|
Kostien
|
500 mg
|
Capsule
|
Mucolytic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
17 March 2023
|
07 February 2028
|
| View |
DRP-4372-04_PI_01.pdf
|
DRP-4372-04
|
Irbesartan + Hydrochlorothiazide
|
IrbeSpeed HCT
|
300mg/12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
Interphil Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
17 February 2027
|
| View |
|
DRP-4478-02
|
Piroxicam
|
ROXICAM
|
10 mg
|
Capsule
|
Anti-inflammatory Agents, Non-Steroids
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
29 June 2023
|
14 June 2028
|
| View |
|
DRP-4778-08
|
Amlodipine (as besilate)
|
Amlospeed 5
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
22 March 2023
|
08 October 2028
|
| View |
|
DRP-4809-02
|
Salbutamol (as sulfate) + Ipratropium Bromide
|
Pulmodual MDI
|
100 mcg/20 mcg per Actuation
|
Metered Dose Inhaler
|
Bronchodilator
|
Midas-Care Pharmaceuticals Pvt. Ltd
|
India
|
Initial (Variation)
|
05 April 2024
|
28 June 2027
|
| View |
|
DRP-5002-02
|
Paracetamol
|
Parazar
|
150 mg/mL (300mg/2mL)
|
Solution for Injection (I.V.)
|
Antipyretic/Analgesic
|
UMEDICA LABORATORIES PVT. LTD.
|
India
|
Renewal
|
08 July 2022
|
10 December 2028
|
| View |
|
DRP-5279-05
|
Montelukast (as sodium)
|
KOTELKAST
|
10 mg
|
Tablet
|
Leukotriene Receptor Antagonist
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
07 April 2024
|
24 April 2029
|
| View |
|
DRP-5313-01
|
Hydrochlorothiazide
|
KOTRAZID
|
50 mg
|
Tablet
|
Diuretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
12 May 2024
|
09 May 2029
|
| View |
|
DRP-5881-05
|
Esomeprazole (as sodium)
|
Esozar
|
40 mg
|
Lyophilized Powder for IV Injection
|
Proton Pump Inhibitor
|
GUFIC BIOSCIENCES LIMITED
|
India
|
CLIDP Conversion
|
08 July 2022
|
09 December 2027
|
| View |
|
DRP-5905-07
|
Isoxsuprine Hydrochloride
|
IKOXPIN
|
10 mg
|
Tablet
|
Tocolytic (Urine Relaxant)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
17 December 2024
|
| View |
|
DRP-6365-01
|
Amino Acids (See Formulation on Reverse Side)
|
Glitter
|
70 mg/mL (7% w/v)
|
Solution for IV Infusion
|
Parenteral Nutrition
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 July 2022
|
02 October 2025
|
| View |
|
DRP-6638-01
|
Omeprazole
|
Kompraz
|
10 mg
|
Delayed-release Capsule
|
Proton Pump Inhibitor
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
12 April 2026
|